VolitionRx Extends Agreement with University Hospital Bonn to Include CE Mark Performance Evaluation

News   Apr 24, 2014

 
VolitionRx Extends Agreement with University Hospital Bonn to Include CE Mark Performance Evaluation
 
 
 

RELATED ARTICLES

Synthetic Material That Detects Enzymatic Activity

News

Scientists integrate protein and polymer building blocks to create stimulus-responsive systems

READ MORE

$26.5M Study on Aggressive Prostate Cancer in African-American Men Begins

News

The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun.

READ MORE

Genetic Factors Leading to Rare Bone Fusion Disorder Identified

News

Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusion

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy